Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-037742
Filing Date
2015-06-17
Accepted
2015-06-17 18:50:47
Documents
2
Period of Report
2015-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 v413297_form3.html 3  
1 FORM 3 v413297_form3.xml 3 1508
2 EXHIBIT 24 v413297_ex24.htm EX-24 6355
  Complete submission text file 0001144204-15-037742.txt   9331
Mailing Address C/O ACHILLION PHARMACEUTICALS INC. 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Graves Kurt (Reporting) CIK: 0001406337 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36199 | Film No.: 15938217

Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations